DLB · Dolby Laboratories, Inc.
Market Cap
$5.75B
Shares
93.67M
DLB metrics
86 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$61.79
Market cap
$5.75B
Price action
19 metricsPrice change (1W)
-7.1%
Price change (30D)
+2.8%
Price change (3M)
+10.5%
Price change (6M)
-5.1%
Price change (YTD)
-4.3%
Price change (1Y)
-14.3%
Trailing year
Price change (5Y)
-37.8%
52-week high
$73.29
52-week low
$48.51
Change from 52-week high
-16.2%
Change from 52-week low
+26.6%
Annualized volatility
29.1%
Beta
0.6
RSI (14D)
53.8
Price vs SMA 50
+9.6%
Price vs SMA 200
+1.6%
Avg volume (3M)
945,278
Relative volume
1.1
Average dollar volume
$52.56M
Company
3 metricsSector
Industrials
Industry
Specialty Business Services
Shares outstanding
93.67M
Valuation
12 metricsP / E (TTM)
26.3
Trailing earnings · reciprocal yield 3.8%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
4.2×
reciprocal yield 23.5%
P / book
2.2
reciprocal yield 44.9%
FCF yield
6.8%
TTM · current market cap
Buyback yield
4.1%
P / FCF
14.6
reciprocal yield 6.8%
P / operating cash flow
13.1
reciprocal yield 7.6%
Earnings yield
3.9%
Historical valuation
8 metricsP / E historical average (3Y)
28.0×
reciprocal yield 3.6%
P / E historical average (5Y)
31.6×
reciprocal yield 3.2%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
2.3%
Trailing 12 months
Payout ratio
59.4%
Shareholder yield
6.4%
Dividend / share (TTM)
$1.44
Dividend growth YoY
+9.1%
Dividend growth streak
5
Last ex-dividend
2026-08-11
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-07-30
Profitability
9 metricsGross margin
87.6%
Operating margin
17.7%
Trailing 12 months
Net margin
16.7%
Gross profit (TTM)
$1.19B
Operating profit (TTM)
$239.10M
Net income (TTM)
$226.18M
Trailing 12 months
Diluted EPS (TTM)
$2.34
FCF margin
29.0%
Effective tax rate
17.6%
Growth
11 metricsRevenue growth YoY
-3.3%
Year over year
Net income growth YoY
-37.9%
Revenue (TTM)
$1.35B
Trailing 12 months
EPS growth YoY
-37.5%
Shares change YoY
-2.5%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.5%
Revenue CAGR (5Y)
+3.0%
EPS CAGR (3Y)
+13.1%
EPS CAGR (5Y)
+3.1%
FCF CAGR (3Y)
+17.2%
FCF CAGR (5Y)
+9.4%
Quality
14 metricsReturn on equity
8.8%
Return on assets
7.2%
Debt / equity
—
Current ratio
3.2
EBITDA (TTM)
$331.94M
Free cash flow (TTM)
$392.67M
Quick ratio
3.1
Interest coverage
—
Net debt / EBITDA
-2.0
Return on invested capital
—
Trailing 12 months
Net cash
$670.05M
Latest balance sheet
Cash & equivalents
$669.39M
Total assets
$3.16B
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$437.60M
Capital expenditures (TTM)
$44.92M
R&D (TTM)
$265.94M
SG&A (TTM)
—
Stock compensation (TTM)
$129.94M
R&D / revenue
19.6%
Stock compensation / revenue
9.6%
Ownership (13F)
3 metrics13F filers
391
13F filer change QoQ
-29
Institutional ownership
66.0%
Short interest
3 metricsShort interest
6.3%
Latest settlement · 6.5 days to cover
Days to cover
6.5d
Short-squeeze score
72 / 100
Insider activity
2 metricsNet insider buying (90D)
−$1.24M
Insider-sentiment score
52 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1308547
CUSIP
25659T107
13F (30d)
282 filings
273 filers
Visit website
Investor relations